Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Health services tags : Biotech-bay save search
FDA Advisory Panel Review of Guardant Health’s Shield™ Blood Test to Screen for Colorectal Cancer to Be Held on May 23
Published: 2024-04-22 (Crawled : 14:00) - biospace.com/
GH | News 4 | $18.1 4.38% 4.2% 1.6M
|
Health Services
|
| O: 4.42%
H: 5.36%
C: 4.83%
fda test review cancer blood for
Guardant Health to Present Data Highlighting Application of Epigenomics to Advance Precision Oncology at 2024 AACR Annual Meeting
Published: 2024-04-03 (Crawled : 14:00) - biospace.com/
GH | News 4 | $18.1 4.38% 4.2% 1.6M
|
Health Services
|
| O: -0.14%
H: 4.43%
C: -5.11%
precision health meeting application
Guardant Health ECLIPSE Study Data Demonstrating Efficacy of Shield Blood-based Test for Colorectal Cancer Screening to be Published in The New England Journal of Medicine
Published: 2024-03-13 (Crawled : 23:00) - biospace.com/
GH | News 4 | $18.1 4.38% 4.2% 1.6M
|
Health Services
|
| O: -0.75%
H: 4.38%
C: 2.7%
test health cancer study
Guardant Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook
Published: 2024-02-22 (Crawled : 00:00) - biospace.com/
GH | News 4 | $18.1 4.38% 4.2% 1.6M
|
Health Services
|
| O: -0.04%
H: 0.71%
C: -1.68%
health year financial results
Quest Diagnostics and Ultima Collaborate to Scale Ultima’s Technology in Fast-Growing Minimal Residual Disease and Whole Genome Sequencing
Published: 2024-01-09 (Crawled : 20:00) - biospace.com/
DGX | News | $137.55 0.62% 0.0% 1.6M
|
Health Services
|
| O: 0.28%
H: 0.65%
C: 0.08%
disease technology diagnostics
Guardant Health to present data at San Antonio Breast Cancer Symposium demonstrating utility of liquid biopsy in biomarker identification, therapy selection and residual disease detection
Published: 2023-11-30 (Crawled : 15:00) - biospace.com/
GH | News 4 | $18.1 4.38% 4.2% 1.6M
|
Health Services
|
| O: 1.51%
H: 3.92%
C: -1.29%
disease breast health symposium biomarker cancer therapy
Invitae to Announce Third Quarter 2023 Financial Results on Wednesday, November 8, 2023
Published: 2023-11-01 (Crawled : 12:00) - biospace.com/
NVTA | News | $0.019 0.0% 22M
|
Health Services
|
| O: -1.18%
H: 0.18%
C: -4.64%
financial results
Landmark Study Reveals Magnitude of Uncertain Results in Clinical Genetic Testing for Hereditary Disease, Points to Evidence-Based Solutions to Reach Definitive Results
Published: 2023-10-25 (Crawled : 20:00) - biospace.com/
NVTA | News | $0.019 0.0% 22M
|
Health Services
|
| O: 2.71%
H: 0.62%
C: -5.77%
genetic reach solutions results study
Guardant Health to Report Third Quarter 2023 Financial Results on November 6, 2023
Published: 2023-10-16 (Crawled : 22:00) - biospace.com/
GH | News 4 | $18.1 4.38% 4.2% 1.6M
|
Health Services
|
| O: -0.15%
H: 4.22%
C: 2.37%
report health financial results
Guardant Health Receives Regulatory Approval in Japan for Guardant360® CDx as Companion Diagnostic to ENHERTU® for Treatment of Non-Small Cell Lung Cancer Patients with HER2 Mutations
Published: 2023-09-05 (Crawled : 18:00) - biospace.com/
GH | News 4 | $18.1 4.38% 4.2% 1.6M
|
Health Services
|
| O: 0.0%
H: 7.57%
C: 0.86%
guardant360 lung japan diagnostic health her2 approval cancer cell treatment companion
Guardant Health Provides Update on COBRA Study, Restates Confidence in MRD Test
Published: 2023-09-01 (Crawled : 22:00) - biospace.com/
GH | News 4 | $18.1 4.38% 4.2% 1.6M
|
Health Services
|
| O: 1.15%
H: 2.4%
C: -11.43%
test health update
Guardant Health to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
Published: 2023-08-31 (Crawled : 22:00) - biospace.com/
MS | News 0 d | $93.85 0.1% 0.0% 4.8M
|
Finance
|
| O: -0.29%
H: 0.0%
C: 0.0%
GH | News 4 | $18.1 4.38% 4.2% 1.6M
|
Health Services
|
| O: 0.08%
H: 0.97%
C: -2.3%
conference health global
Guardant Health to present 17 scientific abstracts highlighting contribution of its blood tests and real-world data to advances in precision oncology and cancer screening at 2023 ASCO annual meeting
Published: 2023-05-31 (Crawled : 14:00) - biospace.com/
GH | News 4 | $18.1 4.38% 4.2% 1.6M
|
Health Services
|
| O: -0.03%
H: 2.65%
C: 2.34%
health asco cancer blood meeting
Guardant Health presents additional information from ECLIPSE study at 2023 Digestive Disease Week on the performance of Shield™ blood test
Published: 2023-05-09 (Crawled : 20:00) - biospace.com/
GH | News 4 | $18.1 4.38% 4.2% 1.6M
|
Health Services
|
| O: -1.1%
H: 4.06%
C: 3.09%
disease test health blood week study
Guardant Health to Participate in the BofA Securities 2023 Healthcare Conference
Published: 2023-04-27 (Crawled : 22:00) - biospace.com/
GH | News 4 | $18.1 4.38% 4.2% 1.6M
|
Health Services
|
| O: 0.62%
H: 3.27%
C: 2.9%
conference health
Guardant Health announces new data to be presented at 2023 Digestive Disease Week showcasing the potential of its blood-based technology to detect colorectal cancer
Published: 2023-04-21 (Crawled : 13:00) - biospace.com/
GH | News 4 | $18.1 4.38% 4.2% 1.6M
|
Health Services
|
| O: 0.77%
H: 0.24%
C: -1.13%
disease health cancer technology week potential
Guardant Health Receives Medicare Coverage for Guardant360 Response™ to Monitor Cancer Patient Response to Immunotherapy
Published: 2023-04-18 (Crawled : 15:00) - biospace.com/
GH | News 4 | $18.1 4.38% 4.2% 1.6M
|
Health Services
|
| O: 1.92%
H: 0.0%
C: -3.65%
health guardant360 cancer immunotherapy response
Guardant Health to Present Data From 14 Studies Highlighting Advances in Precision Oncology and Cancer Screening at 2023 AACR Annual Meeting
Published: 2023-04-11 (Crawled : 14:00) - biospace.com/
GH | News 4 | $18.1 4.38% 4.2% 1.6M
|
Health Services
|
| O: 0.63%
H: 3.41%
C: 2.16%
health cancer meeting
Guardant Health collaborates with The Ohio State University Comprehensive Cancer Center to study colorectal cancer screening adherence
Published: 2023-03-21 (Crawled : 18:00) - biospace.com/
GH | News 4 | $18.1 4.38% 4.2% 1.6M
|
Health Services
|
| O: 0.35%
H: 3.61%
C: 1.96%
health state cancer study
Guardant Health submits premarket approval application to the U.S. Food and Drug Administration for Shield™ blood test
Published: 2023-03-10 (Crawled : 17:00) - biospace.com/
GH | News 4 | $18.1 4.38% 4.2% 1.6M
|
Health Services
|
| O: -0.59%
H: 0.3%
C: -6.61%
blood drug test health application approval food
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.